Sensorium Therapeutics
Boston, United States
Sensorium Therapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for brain and mental health conditions. Utilizing its proprietary SensAI platform, the company integrates artificial intelligence, chemistry, and neuroscience to explore and decode the complexities of human biology. The company’s lead product, SENS-01, a first-in-class treatment for anxiety, has received IND clearance from the FDA to enter Phase 1 clinical trials. With a commitment to advancing mental health through re-engineering naturally co-evolved molecules, Sensorium aims to overcome the limitations of existing treatments, enhancing patient outcomes through a holistic and precise approach.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2021
- Website
- www.sensorium.bio/
Only accessible to MedStartr community members.
Join nowWhat do you think of Sensorium Therapeutics?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now